The Hyderabad based Bharat Biotech International Private Limited manufactured COVAXIN has been found effective against the new Delta Plus variant of the Wuhan virus. The latest development regarding the Novel…
The Novel Coronavirus (COVID-19) cases in India reported a dip in cases for the second consecutive day. On the 11th of May, India recorded 3,29,942 new COVID-19 cases. In addition…
On the 10th May, India’s Novel Coronavirus (COVID-19) single day cases reduced to 3.66 lakhs. After recording over 4 lakh fresh cases for four consecutive days, India witnessed a single…
On the 7th of May, India reported the highest single day spike of the Novel Coronavirus or COVID-19. In the past 24 hours with 4.14 lakh new cases, the Country…
After witnessing a decline in the Novel Coronavirus (COVID-19) cases, India once again reported the highest 4.12 lakh new cases. On the 7th of May, the Union Health Ministry confirmed…
India’s total tally of the Novel Coronavirus or COVID-19 witnessed a slight dip with 3.57 lakh cases. In the past 24 hours, India reported 3,57,229 new infections, compared to 4…
Telangana High Court on the 18th of March, directed the Telangana Government to strictly implement the Novel Coronavirus or COVID-19 guidelines of the Indian Council of Medical Research (ICMR.) The…
Balram Bhargava, the Chief of the Indian Council of Medical Research (ICMR) asked the Bharat Biotech International Private Limited to take consent from volunteers. On the 5th of January, the…
Hyderabad based pharma company, Bharat Biotech International Private Limited and the Indian Council Medical Research (ICMR) prepared vaccine, for the Novel Coronavirus or COVID-19 entered the third phase of the…
The Nizam’s Institute of Medical Sciences (NIMS) of Hyderabad started the phase-III human clinical trials for COVAXIN. The trials begin from the 16th of November. A medical team at NIMS…
